Insider Transactions in Q2 2022 at Evelo Biosciences, Inc. (EVLO)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2022
|
David R Epstein Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,927
+2.59%
|
-
|
|
May 31
2022
|
David R Epstein Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,925
+2.73%
|
-
|
|
May 27
2022
|
Flagship Ventures Fund Iv General Partner LLC |
BUY
Open market or private purchase
|
Indirect |
27,397,259
+37.75%
|
$27,397,259
$1.46 P/Share
|
|
May 27
2022
|
David R Epstein Director |
BUY
Open market or private purchase
|
Direct |
17,123
+16.92%
|
$17,123
$1.46 P/Share
|
|
May 27
2022
|
Lord Ara Darzi Director |
BUY
Open market or private purchase
|
Direct |
342,465
+50.0%
|
$342,465
$1.46 P/Share
|
|
May 27
2022
|
Duncan Mc Hale Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
34,246
+50.0%
|
$34,246
$1.46 P/Share
|
|
May 02
2022
|
David R Epstein Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,926
+3.61%
|
-
|